Mitochondrial- and endoplasmic reticulum-associated oxidative stress in alzheimers disease: From pathogenesis to biomarkers

International Journal of Cell Biology

Volumn , Issue , 2012, Pages

  Ferreiro, E ^a   Baldeiras, I ^b,c   Ferreira, I L ^a   Costa, R O ^a   Rego, A C ^a,b   Pereira, C F ^a,b   Oliveira, C R ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 4 PHENYLBUTYRIC ACID; ACETYL LEVO CARNITINE CARNITINE; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL PLUS TRIPHENYLPHOSPHONIUM; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; ANTIOXIDANT; BIOLOGICAL MARKER; CALCIUM; CATALASE; DANTROLENE; DIMEBON; DIZOCILPINE; GLUTATHIONE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; IFENPRODIL; ISOPROSTANE DERIVATIVE; MALONALDEHYDE; MEMANTINE; MITOCHONDRIAL PROTEIN; MITOQUINONE MESYLATE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REACTIVE OXYGEN METABOLITE; SCHILLER PEPTIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; XESTOSPONGIN C;

ALZHEIMER DISEASE; AMNESIA; APOPTOSIS; BODY FLUID; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CELL DAMAGE; CEREBROSPINAL FLUID LEVEL; COGNITIVE DEFECT; DISEASE COURSE; DNA FRAGMENTATION; DOSE RESPONSE; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; GENE EXPRESSION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; LIPID PEROXIDATION; MEMORY DISORDER; MILD COGNITIVE IMPAIRMENT; MITOCHONDRION; MITOCHONDRION DYSFUNCTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; SYNAPTIC LOSS; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 84863688106     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2012/735206     Document Type: Review

References (292)

1. Hardy J., Selkoe D. J., The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 2002 297 5580 353 356 (Pubitemid 34790756)
2. Oddo S., Caccamo A., Shepherd J. D., Murphy M. P., Golde T. E., Kayed R., Metherate R., Mattson M. P., Akbari Y., LaFerla F. M., Triple-transgenic model of Alzheimer's Disease with plaques and tangles: intracellular A and synaptic dysfunction Neuron 2003 39 3 409 421 (Pubitemid 36937044)
3. Swerdlow R. H., Brain aging, Alzheimer's disease, and mitochondria Biochimica et Biophysica Acta 2011 1812 12 1630 1639
4. Miller D. L., Papayannopoulos I. A., Styles J., Bobin S. A., Lin Y. Y., Biemann K., Iqbal K., Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease Archives of Biochemistry and Biophysics 1993 301 1 41 52 (Pubitemid 23227174)
5. Teng C. C., Yang Y. T., Chen Y. C., Kuo Y. M., Sze C. I., Role of WWOX/WOX1 in Alzheimer's disease pathology and in cell death signaling Frontiers in Bioscience 2012 4 1951 1965
6. Christen Y., Oxidative stress and Alzheimer disease American Journal of Clinical Nutrition 2000 71 2 621S 629S (Pubitemid 30061247)
7. Kregel K. C., Zhang H. J., An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations American Journal of Physiology 2007 292 1 R18 R36
8. Patten D. A., Germain M., Kelly M. A., Slack R. S., Reactive oxygen species: stuck in the middle of neurodegeneration Journal of Alzheimer's Disease 2010 20 supplement 2 S357 S367
9. Cardoso S. M., Santana I., Swerdlow R. H., Oliveira C. R., Mitochondria dysfunction of Alzheimer's disease cybrids enhances A toxicity Journal of Neurochemistry 2004 89 6 1417 1426 (Pubitemid 38802663)
10. Moreira P. I., Cardoso S. M., Santos M. S., Oliveira C. R., The key role of mitochondria in Alzheimer's disease Journal of Alzheimer's Disease 2006 9 2 101 110 (Pubitemid 44078638)
11. Lovell M. A., Ehmann W. D., Butler S. M., Markesbery W. R., Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease Neurology 1995 45 8 1594 1601
12. Marcus D. L., Thomas C., Rodriguez C., Simberkoff K., Tsai J. S., Strafaci J. A., Freedman M. L., Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease Experimental Neurology 1998 150 1 40 44 (Pubitemid 28146421)
13. Ramassamy C., Averill D., Beffert U., Bastianetto S., Theroux L., Lussier-Cacan S., Cohn J. S., Christen Y., Davignon J., Quirion R., Poirier J., Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotype Free Radical Biology and Medicine 1999 27 5-6 544 553 (Pubitemid 29408640)
14. Keller J. N., Schmitt F. A., Scheff S. W., Ding Q., Chen Q., Butterfield D. A., Markesbery W. R., Evidence of increased oxidative damage in subjects with mild cognitive impairment Neurology 2005 64 7 1152 1156
15. Markesbery W. R., Lovell M. A., Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease Neurobiology of Aging 1998 19 1 33 36 (Pubitemid 28167792)
16. Montine K. S., Oison S. J., Amarnath V., Whetsell W. O., Graham D. G., Montine T. J., Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4 American Journal of Pathology 1997 150 2 437 443 (Pubitemid 27073773)
17. Butterfield D. A., Reed T., Perluigi M., De Marco C., Coccia R., Cini C., Sultana R., Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment Neuroscience Letters 2006 397 3 170 173
18. Butterfield D. A., Poon H. F., Clair D. S., Keller J. N., Pierce W. M., Klein J. B., Markesbery W. R., Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease Neurobiology of Disease 2006 22 2 223 232
19. Williams T. I., Lynn B. C., Markesbery W. R., Lovell M. A., Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in Mild Cognitive Impairment and early Alzheimer's disease Neurobiology of Aging 2006 27 8 1094 1099 (Pubitemid 43850642)
20. Pratic D., Lee V. M. Y., Trojanowski J. Q., Rokach J., Fitzgerald G. A., Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo The FASEB Journal 1998 12 15 1777 1783 (Pubitemid 28553673)
21. Yao Y., Zhukareva V., Sung S., Clark C. M., Rokach J., Lee V. M. Y., Trojanowski J. Q., Pratic D., Enhanced brain levels of 8,12-iso-iPF2 -VI differentiate AD from frontotemporal dementia Neurology 2003 61 4 475 478 (Pubitemid 37025363)
22. Reich E. E., Markesbery W. R., Roberts L. J., Swift L. L., Morrow J. D., Montine T. J., Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease American Journal of Pathology 2001 158 1 293 297 (Pubitemid 32096495)
23. Markesbery W. R., Kryscio R. J., Lovell M. A., Morrow J. D., Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment Annals of Neurology 2005 58 5 730 735 (Pubitemid 41552548)
24. Forman M. S., Mufson E. J., Leurgans S., Pratico D., Joyce S., Leight S., Lee V. M. Y., Trojanowski J. Q., Cortical biochemistry in MCI and Alzheimer disease: lack of correlation with clinical diagnosis Neurology 2007 68 10 757 763 (Pubitemid 46667901)
25. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S. P., Wu J. F., Carney J. M., Lovell M., Markesbery W. R., Butterfield D. A., Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation Journal of Neurochemistry 1995 65 5 2146 2156
26. Lyras L., Cairns N. J., Jenner A., Jenner P., Halliwell B., An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease Journal of Neurochemistry 1997 68 5 2061 2069 (Pubitemid 27176143)
27. Smith M. A., Richey Harris P. L., Sayre L. M., Beckman J. S., Perry G., Widespread peroxynitrite-mediated damage in Alzheimer's disease Journal of Neuroscience 1997 17 8 2653 2657 (Pubitemid 27154998)
28. Butterfield D. A., Reed T. T., Perluigi M., De Marco C., Coccia R., Keller J. N., Markesbery W. R., Sultana R., Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease Brain Research 2007 1148 1 243 248 (Pubitemid 46602178)
29. Sultana R., Butterfield D. A., Oxidatively modified, mitochondria- relevant brain proteins in subjects with Alzheimer disease and mild cognitive impairment Journal of Bioenergetics and Biomembranes 2009 41 5 441 446
30. Castegna A., Thongboonkerd V., Klein J. B., Lynn B., Markesberyl W. R., Butterfield D. A., Proteomic identification of nitrated proteins in Alzheimer's disease brain Journal of Neurochemistry 2003 85 6 1394 1401 (Pubitemid 36702552)
31. Sultana R., Boyd-Kimball D., Poon H. F., Cai J., Pierce W. M., Klein J. B., Merchant M., Markesbery W. R., Butterfield D. A., Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: an approach to understand pathological and biochemical alterations in AD Neurobiology of Aging 2006 27 11 1564 1576 (Pubitemid 44344840)
32. Reed T., Perluigi M., Sultana R., Pierce W. M., Klein J. B., Turner D. M., Coccia R., Markesbery W. R., Butterfield D. A., Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease Neurobiology of Disease 2008 30 1 107 120
33. Anderson A. J., Su J. H., Cotman C. W., DNA damage and apoptosis in Alzheimer's disease: colocalization with c-Jun immunoreactivity, relationship to brain area, and effect of postmortem delay Journal of Neuroscience 1996 16 5 1710 1719
34. Colurso G. J., Nilson J. E., Vervoort L. G., Quantitative assessment of DNA fragmentation and beta-amyloid deposition in insular cortex and midfrontal gyrus from patients with Alzheimer's disease Life Sciences 2003 73 14 1795 1803 (Pubitemid 36897740)
35. Lucassen P. J., Chung W. C. J., Kamphorst W., Swaab D. F., DNA damage distribution in the human brain as shown by in situ end labeling; area-specific differences in aging and Alzheimer disease in the absence of apoptotic morphology Journal of Neuropathology and Experimental Neurology 1997 56 8 887 900 (Pubitemid 27329110)
36. Adamec E., Vonsattel J. P., Nixon R. A., DNA strand breaks in Alzheimer's disease Brain Research 1999 849 1-2 67 77
37. Mecocci P., MacGarvey U., Beal M. F., Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease Annals of Neurology 1994 36 5 747 751 (Pubitemid 24337634)
38. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E. K., Jones P. K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C. S., Petersen R. B., Smith M. A., Oxidative damage is the earliest event in Alzheimer disease Journal of Neuropathology and Experimental Neurology 2001 60 8 759 767 (Pubitemid 32678256)
39. Wang J., Markesbery W. R., Lovell M. A., Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment Journal of Neurochemistry 2006 96 3 825 832
40. Nunomura A., Perry G., Pappolla M. A., Wade R., Hirai K., Chiba S., Smith M. A., RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease Journal of Neuroscience 1999 19 6 1959 1964 (Pubitemid 29133374)
41. Shan X., Tashiro H., Lin C. L. G., The identification and characterization of oxidized RNAs in Alzheimer's disease Journal of Neuroscience 2003 23 12 4913 4921 (Pubitemid 36793217)
42. Shan X., Lin C. L. G., Quantification of oxidized RNAs in Alzheimer's disease Neurobiology of Aging 2006 27 5 657 662
43. Lovell M. A., Markesbery W. R., Oxidatively modified RNA in mild cognitive impairment Neurobiology of Disease 2008 29 2 169 175
44. Ansari M. A., Scheff S. W., Oxidative stress in the progression of alzheimer disease in the frontal cortex Journal of Neuropathology and Experimental Neurology 2010 69 2 155 167
45. Ansari M. A., Scheff S. W., NADPH-oxidase activation and cognition in Alzheimer disease progression Free Radical Biology and Medicine 2011 51 1 171 178
46. Sultana R., Piroddi M., Galli F., Butterfield D. A., Protein levels and activity of some antioxidant enzymes in hippocampus of subjects with amnestic mild cognitive impairment Neurochemical Research 2008 33 12 2540 2546
47. Te Koppele J. M., Lucassen P. J., Sakkee A. N., Van Asten J. G., Ravid R., Swaab D. F., Van Bezooijen C. F. A., 8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease Neurobiology of Aging 1996 17 6 819 826 (Pubitemid 27022733)
48. Sarti P., Forte E., Mastronicola D., Giuffre A., Arese M., Cytochrome c oxidase and nitric oxide in action: molecular mechanisms and pathophysiological implications Biochimica et Biophysica Acta 2012 1817 4 610 619
49. Hybertson B. M., Gao B., Bose S. K., McCord J. M., Oxidative stress in health and disease: the therapeutic potential of Nrf2 activation Molecular Aspects of Medicine 2011 32 46 234 246
50. Pagani L., Eckert A., Amyloid-beta interaction with mitochondria International Journal of Alzheimer's Disease 2011 2011 12
51. Wirths O., Multhaup G., Bayer T. A., A modified -amyloid hypothesis: intraneuronal accumulation of the -amyloid peptidethe first step of a fatal cascade Journal of Neurochemistry 2004 91 3 513 520 (Pubitemid 39431147)
52. Nagele R. G., D'Andrea M. R., Anderson W. J., Wang H. Y., Intracellular accumulation of -amyloid142 in neurons is facilitated by the 7 nicotinic acetylcholine receptor in Alzheimer's disease Neuroscience 2002 110 2 199 211 (Pubitemid 34214939)
53. Caspersen C., Wang N., Yao J., Sosunov A., Chen X., Lustbader J. W., Xu H. W., Stern D., McKhann G., Yan S. D., Mitochondrial A : a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease The FASEB Journal 2005 19 14 2040 2041 (Pubitemid 41759758)
54. Hansson Petersen C. A., Alikhani N., Behbahani H., Wiehager B., Pavlov P. F., Alafuzoff I., Leinonen V., Ito A., Winblad B., Glaser E., Ankarcrona M., The amyloid -peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae Proceedings of the National Academy of Sciences of the United States of America 2008 105 35 13145 13150
55. Ferreira I. L., Resende R., Ferreiro E., Rego A. C., Pereira C. F., Multiple defects in energy metabolism in Alzheimer's disease Current Drug Targets 2010 11 10 1193 1206
56. Palmer A. M., The activity of the pentose phosphate pathway is increased in response to oxidative stress in Alzheimer's disease Journal of Neural Transmission 1999 106 3-4 317 328 (Pubitemid 29196935)
57. Cardoso S. M., Proena M. T., Santos S., Santana I., Oliveira C. R., Cytochrome c oxidase is decreased in Alzheimer's disease platelets Neurobiology of Aging 2004 25 1 105 110 (Pubitemid 37522198)
58. Rizzuto R., Brini M., Murgia M., Pozzan T., Microdomains with high Ca 2+ close to IP 3 -sensitive channels that are sensed by neighboring mitochondria Science 1993 262 5134 744 747 (Pubitemid 23350694)
59. Du H., Guo L., Yan S., Sosunov A. A., McKhann G. M., Yan S. S., Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model Proceedings of the National Academy of Sciences of the United States of America 2010 107 43 18670 18675
60. Reddy P. H., Tripathi R., Troung Q., Tirumala K., Reddy T. P., Anekonda V., Shirendeb U. P., Calkins M. J., Reddy A. P., Mao P., Manczak M., Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics Biochimica et Biophysica Acta 2012 1822 5 639 649
61. Kang D. E., Roh S. E., Woo J. A., Liu T., Bu J. H., Jung A. R., Lim Y., The interface between cytoskeletal aberrations and mitochondrial dysfunction in Alzheimer's disease and related disorders Experimental Neurobiology 2011 20 2 67 80
62. McManus M. J., Murphy M. P., Franklin J. L., The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease The Journal of Neuroscience 2011 31 44 15703 15715
63. Hashimoto M., Bogdanovic N., Volkmann I., Aoki M., Winblad B., Tjernberg L. O., Analysis of microdissected human neurons by a sensitive ELISA reveals a correlation between elevated intracellular concentrations of A 42 and Alzheimer's disease neuropathology Acta Neuropathologica 2010 119 5 543 554
64. Moreira P. I., Santos M. S., Moreno A., Oliveira C., Amyloid -peptide promotes permeability transition pore in brain mitochondria Bioscience Reports 2001 21 6 789 800
65. Manczak M., Anekonda T. S., Henson E., Park B. S., Quinn J., Reddy P. H., Mitochondria are a direct site of A accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression Human Molecular Genetics 2006 15 9 1437 1449
66. Casley C. S., Canevari L., Land J. M., Clark J. B., Sharpe M. A., -Amyloid inhibits integrated mitochondrial respiration and key enzyme activities Journal of Neurochemistry 2002 80 1 91 100 (Pubitemid 34614581)
67. Wang X., Su B., Lee H. G., Li X., Perry G., Smith M. A., Zhu X., Impaired balance of mitochondrial fission and fusion in Alzheimer's disease Journal of Neuroscience 2009 29 28 9090 9103
68. Smith I. F., Green K. N., LaFerla F. M., Calcium dysregulation in Alzheimer's disease: recent advances gained from genetically modified animals Cell Calcium 2005 38 3-4 427 437 (Pubitemid 41283281)
69. Alberdi E., Snchez-Gmez M. V., Cavaliere F., Pérez-Samartn A., Zugaza J. L., Trullas R., Domercq M., Matute C., Amyloid oligomers induce Ca 2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors Cell Calcium 2010 47 3 264 272
70. Du H., Yan S. S., Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta Biochimica et Biophysica Acta 2010 1802 1 198 204
71. Deshpande A., Mina E., Glabe C., Busciglio J., Different conformations of amyloid induce neurotoxicity by distinct mechanisms in human cortical neurons Journal of Neuroscience 2006 26 22 6011 6018 (Pubitemid 44318367)
72. Reddy P. H., Beal M. F., Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease Trends in Molecular Medicine 2008 14 2 45 53
73. Stadelmann C., Brck W., Bancher C., Jellinger K., Lassmann H., Alzheimer disease: DNA fragmentation indicates increased neuronal vulnerability, but not apoptosis Journal of Neuropathology and Experimental Neurology 1998 57 5 456 464 (Pubitemid 28237329)
74. Ferreiro E., Eufrsio A., Pereira C., Oliveira C. R., Rego A. C., Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells Journal of Alzheimer's Disease 2007 12 3 223 228 (Pubitemid 350179253)
75. Rohn T. T., Vyas V., Hernandez-Estrada T., Nichol K. E., Christie L. A., Head E., Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2 Journal of Neuroscience 2008 28 12 3051 3059 (Pubitemid 351442294)
76. Baloyannis S. J., Mitochondria are related to synaptic pathology in Alzheimer's disease International Journal of Alzheimer's Disease 2011 2011 7
77. Calkins M. J., Reddy P. H., Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons Biochimica et Biophysica Acta 2011 1812 4 507 513
78. Brown M. R., Sullivan P. G., Geddes J. W., Synaptic mitochondria are more susceptible to Ca 2+ overload than nonsynaptic mitochondria Journal of Biological Chemistry 2006 281 17 11658 11668 (Pubitemid 43855423)
79. Mattson M. P., Partin J., Begley J. G., Amyloid -peptide induces apoptosis-related events in synapses and dendrites Brain Research 1998 807 1-2 167 176 (Pubitemid 29005249)
80. Dalton G. L., Wu D. C., Wang Y. T., Floresco S. B., Phillips A. G., NMDA GluN2A and GluN2B receptors play separate roles in the induction of LTP and LTD in the amygdala and in the acquisition and extinction of conditioned fear Neuropharmacology 2012 62 2 797 806
81. Dingledine R., Borges K., Bowie D., Traynelis S. F., The glutamate receptor ion channels Pharmacological Reviews 1999 51 1 7 61 (Pubitemid 29113865)
82. Hollmann M., Heinemann S., Cloned glutamate receptors Annual Review of Neuroscience 1994 17 31 108 (Pubitemid 24117025)
83. Cull-Candy S. G., Leszkiewicz D. N., Role of distinct NMDA receptor subtypes at central synapses Science's STKE 2004 2004 255, article re16
84. Domingues A., Almeida S., da Cruz e Silva E. F., Oliveira C. R., Rego A. C., Toxicity of -amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-d-aspartate receptor subunits Neurochemistry International 2007 50 6 872 880 (Pubitemid 46710199)
85. Guemez-Gamboa A., Estrada-Sanchez A. M., Montiel T., Paramo B., Massieu L., Moran J., Activation of NOX2 by the stimulation of ionotropic and metabotropic glutamate receptors contributes to glutamate neurotoxicity in vivo through the production of reactive oxygen species and calpain activation Journal of Neuropathology Experimental Neurology 2011 70 11 1020 1035
86. Nguyen D., Alavi M. V., Kim K. Y., Kang T., Scott R. T., Noh Y. H., Lindsey J. D., Wissinger B., Ellisman M. H., Weinreb R. N., Perkins G. A., Ju W. K., A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics Cell Death and Disease 2011 2 12, article e240
87. Reisberg B., Doody R., Stffler A., Schmitt F., Ferris S., Mbius H. J., Memantine in moderate-to-severe Alzheimer's disease New England Journal of Medicine 2003 348 14 1333 1341 (Pubitemid 36384100)
88. De Felice F. G., Velasco P. T., Lambert M. P., Viola K., Fernandez S. J., Ferreira S. T., Klein W. L., A oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine Journal of Biological Chemistry 2007 282 15 11590 11601 (Pubitemid 47100810)
89. Ferreira I. L., Bajouco L. M., Mota S. I., Auberson Y. P., Oliveira C. R., Rego A. C., Amyloid beta peptide 142 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures Cell Calcium 2012 51 2 95 106
90. Shankar G. M., Bloodgood B. L., Townsend M., Walsh D. M., Selkoe D. J., Sabatini B. L., Natural oligomers of the Alzheimer amyloid- protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway Journal of Neuroscience 2007 27 11 2866 2875 (Pubitemid 46438992)
91. Snyder E. M., Nong Y., Almeida C. G., Paul S., Moran T., Choi E. Y., Nairn A. C., Salter M. W., Lombroso P. J., Gouras G. K., Greengard P., Regulation of NMDA receptor trafficking by amyloid- Nature Neuroscience 2005 8 8 1051 1058 (Pubitemid 41061516)
92. Goto Y., Niidome T., Akaike A., Kihara T., Sugimoto H., Amyloid -peptide preconditioning reduces glutamate-induced neurotoxicity by promoting endocytosis of NMDA receptor Biochemical and Biophysical Research Communications 2006 351 1 259 265 (Pubitemid 44635435)
93. Deshpande A., Kawai H., Metherate R., Glabe C. G., Busciglio J., A role for synaptic zinc in activity-dependent a oligomer formation and accumulation at excitatory synapses Journal of Neuroscience 2009 29 13 4004 4015
94. Papadia S., Hardingham G. E., The dichotomy of NMDA receptor signaling Neuroscientist 2007 13 6 572 579 (Pubitemid 350077306)
95. Bordji K., Becerril-Ortega J., Nicole O., Buisson A., Activation of extrasynaptic, but not synaptic, NMDA receptors modifies amyloid precursor protein expression pattern and increases amyloid- production Journal of Neuroscience 2010 30 47 15927 15942
96. Soriano F. X., Papadia S., Hofmann F., Hardingham N. R., Bading H., Hardingham G. E., Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability Journal of Neuroscience 2006 26 17 4509 4518 (Pubitemid 44315350)
97. Hardingham G. E., Coupling of the NMDA receptor to neuroprotective and neurodestructive events Biochemical Society Transactions 2009 37 6 1147 1160
98. Hardingham G. E., Bading H., The Yin and Yang of NMDA receptor signalling Trends in Neurosciences 2003 26 2 81 89 (Pubitemid 36110542)
99. Léveillé F., El Gaamouch F., Gouix E., Lecocq M., Lobner D., Nicole O., Buisson A., Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors The FASEB Journal 2008 22 12 4258 4271
100. Hardingham G. E., Fukunaga Y., Bading H., Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways Nature Neuroscience 2002 5 5 405 414 (Pubitemid 34454245)
101. Ivanov A., Pellegrino C., Rama S., Dumalska I., Salyha Y., Ben-Ari Y., Medina I., Opposing role of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-regulated kinases (ERK) activity in cultured rat hippocampal neurons Journal of Physiology 2006 572 3 789 798
102. Stanika R. I., Pivovarova N. B., Brantner C. A., Watts C. A., Winters C. A., Andrews S. B., Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity Proceedings of the National Academy of Sciences of the United States of America 2009 106 24 9854 9859
103. Zhou M., Baudry M., Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors Journal of Neuroscience 2006 26 11 2956 2963
104. Liu Y., Tak P. W., Aarts M., Rooyakkers A., Liu L., Ted W. L., Dong C. W., Lu J., Tymianski M., Craig A. M., Yu T. W., NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo Journal of Neuroscience 2007 27 11 2846 2857 (Pubitemid 46438991)
105. Lin J. H., Walter P., Yen T. S. B., Endoplasmic reticulum stress in disease pathogenesis Annual Review of Pathology 2008 3 399 425 (Pubitemid 351488287)
106. Walter P., Ron D., The unfolded protein response: from stress pathway to homeostatic regulation Science 2011 334 6059 1081 1086
107. Kim I., Xu W., Reed J. C., Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities Nature Reviews Drug Discovery 2008 7 12 1013 1030
108. Ma Y., Brewer J. W., Alan Diehl J., Hendershot L. M., Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response Journal of Molecular Biology 2002 318 5 1351 1365 (Pubitemid 34754003)
109. Brush M. H., Weiser D. C., Shenolikar S., Growth arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1 to the endoplasmic reticulum and promotes dephosphorylation of the subunit of eukaryotic translation initiation factor 2 Molecular and Cellular Biology 2003 23 4 1292 1303 (Pubitemid 36177038)
110. Novoa I., Zeng H., Harding H. P., Ron D., Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2 Journal of Cell Biology 2001 153 5 1011 1022
111. Kojima E., Takeuchi A., Haneda M., Yagi A., Hasegawa T., Yamaki K. I., Takeda K., Akira S., Shimokata K., Isobe K. I., The function of GADD34 is a recovery from a shutoff of protein synthesis induced by ER stress: elucidation by GADD34-deficient mice The FASEB Journal 2003 17 11 1573 1575
112. McCullough K. D., Martindale J. L., Klotz L. O., Aw T. Y., Holbrook N. J., Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bc12 and perturbing the cellular redox state Molecular and Cellular Biology 2001 21 4 1249 1259 (Pubitemid 32114973)
113. Zinszner H., Kuroda M., Wang X., Batchvarova N., Lightfoot R. T., Remotti H., Stevens J. L., Ron D., CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum Genes and Development 1998 12 7 982 995 (Pubitemid 28204605)
114. Xu C., Bailly-Maitre B., Reed J. C., Endoplasmic reticulum stress: cell life and death decisions Journal of Clinical Investigation 2005 115 10 2656 2664 (Pubitemid 41434389)
115. Zhao L., Ackerman S. L., Endoplasmic reticulum stress in health and disease Current Opinion in Cell Biology 2006 18 4 444 452 (Pubitemid 44026518)
116. Mattson M. P., Gary D. S., Chan S. L., Duan W., Perturbed endoplasmic reticulum function, synaptic apoptosis and the pathogenesis of Alzheimer's disease Biochemical Society Symposium 2001 67 151 162 (Pubitemid 33602683)
117. LaFerla F. M., Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease Nature Reviews Neuroscience 2002 3 11 862 872
118. Katayama T., Imaizumi K., Manabe T., Hitomi J., Kudo T., Tohyama M., Induction of neuronal death by ER stress in Alzheimer's disease Journal of Chemical Neuroanatomy 2004 28 1-2 67 78 (Pubitemid 39198955)
119. Lee J. H., Won S. M., Suh J., Son S. J., Moon G. J., Park U. J., Gwag B. J., Induction of the unfolded protein response and cell death pathway in alzheimer's disease, but not in aged Tg2576 mice Experimental and Molecular Medicine 2010 42 5 386 394
120. Hoozemans J. J. M., Veerhuis R., Van Haastert E. S., Rozemuller J. M., Baas F., Eikelenboom P., Scheper W., The unfolded protein response is activated in Alzheimer's disease Acta Neuropathologica 2005 110 2 165 172 (Pubitemid 41245205)
121. Hoozemans J. J. M., Van Haastert E. S., Nijholt D. A. T., Rozemuller A. J. M., Eikelenboom P., Scheper W., The unfolded protein response is activated in pretangle neurons in alzheimer's disease hippocampus American Journal of Pathology 2009 174 4 1241 1251
122. Unterberger U., Hftberger R., Gelpi E., Flicker H., Budka H., Voigtlnder T., Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo Journal of Neuropathology and Experimental Neurology 2006 65 4 348 357 (Pubitemid 44264832)
123. Nijholt D. A. T., De Graaf T. R., Van Haastert E. S., Oliveira A. O., Berkers C. R., Zwart R., Ovaa H., Baas F., Hoozemans J. J. M., Scheper W., Endoplasmic reticulum stress activates autophagy but not the proteasome in neuronal cells: implications for Alzheimer's disease Cell Death and Differentiation 2011 18 6 1071 1081
124. Song S., Lee H., Kam T. I., Mei L. T., Lee J. Y., Noh J. Y., Sang M. S., Soo J. S., Kong Y. Y., Nakagawa T., Chung C. W., Choi D. Y., Oubrahim H., Jung Y. K., E2-25K/Hip-2 regulates caspase-12 in ER stress-mediated A neurotoxicity Journal of Cell Biology 2008 182 4 675 684
125. Katayama T., Imaizumi K., Sato N., Miyoshi K., Kudo T., Hitomi J., Morihara T., Yoneda T., Gomi F., Mori Y., Nakano Y., Takeda J., Tsuda T., Itoyama Y., Murayama O., Takashima A., George -. P. S., Takeda M., Tohyama M., Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response Nature Cell Biology 1999 1 8 479 485 (Pubitemid 129503667)
126. Sato N., Imaizumi K., Manabe T., Taniguchi M., Hitomi J., Katayama T., Yoneda T., Morihara T., Yasuda Y., Takagi T., Kudo T., Tsuda T., Itoyama Y., Makifuchi T., Fraser P. E., St George-Hyslop P., Tohyama M., Increased production of -amyloid and vulnerability to endoplasmic reticulum stress by an aberrant spliced form of presenilin 2 Journal of Biological Chemistry 2001 276 3 2108 2114 (Pubitemid 32111741)
127. Selwood S. P., Parvathy S., Cordell B., Ryan H. S., Oshidari F., Vincent V., Yesavage J., Lazzeroni L. C., Murphy G. M., Gene expression profile of the PDAPP mouse model for Alzheimer's disease with and without Apolipoprotein E Neurobiology of Aging 2009 30 4 574 590
128. Ohta K., Mizuno A., Li S., Itoh M., Ueda M., Ohta E., Hida Y., Wang M. X., Furoi M., Tsuzuki Y., Sobajima M., Bohmoto Y., Fukushima T., Kobori M., Inuzuka T., Nakagawa T., Endoplasmic reticulum stress enhances gamma-secretase activity Biochemical and Biophysical Research Communications 2011 416 3-4 362 366
129. Muresan V., Muresan Z., A persistent stress response to impeded axonal transport leads to accumulation of amyloid-beta in the endoplasmic reticulum, and is a probable cause of sporadic Alzheimer's disease Neurodegenerative Diseases 2012 10 14 60 63
130. Umeda T., Tomiyama T., Sakama N., Tanaka S., Lambert M. P., Klein W. L., Mori H., Intraneuronal amyloid oligomers cause cell death via endoplasmic reticulum stress, endosomal/lysosomal leakage, and mitochondrial dysfunction in vivo Journal of Neuroscience Research 2011 89 7 1031 1042
131. Quiroz-Baez R., Ferrera P., Rosendo-Gutierrez R., Moran J., Bermudez-Rattoni F., Arias C., Caspase-12 activation is involved in amyloid-beta protein-induced synaptic toxicity Journal of Alzheimer's Disease 2011 26 3 467 476
132. Chafekar S. M., Zwart R., Veerhuis R., Vanderstichele H., Baas F., Scheper W., Increased A 142 production sensitizes neuroblastoma cells for ER stress toxicity Current Alzheimer Research 2008 5 5 469 474
133. Takahashi K., Niidome T., Akaike A., Kihara T., Sugimoto H., Amyloid precursor protein promotes endoplasmic reticulum stress-induced cell death via C/EBP homologous protein-mediated pathway Journal of Neurochemistry 2009 109 5 1324 1337
134. Nishitsuji K., Tomiyama T., Ishibashi K., Ito K., Teraoka R., Lambert M. P., Klein W. L., Mori H., The E693 mutation in amyloid precursor protein increases intracellular accumulation of amyloid oligomers and causes endoplasmic reticulum stress-induced apoptosis in cultured cells American Journal of Pathology 2009 174 3 957 969
135. Ferreiro E., Resende R., Costa R., Oliveira C. R., Pereira C. M. F., An
136. Resende R., Ferreiro E., Pereira C., Resende de Oliveira C., Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 142: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death Neuroscience 2008 155 3 725 737
137. Szegezdi E., MacDonald D. C., Chonghaile T. N., Gupta S., Samali A., Bcl-2 family on guard at the ER American Journal of Physiology 2009 296 5 C941 C953
138. Taguchi J., Fujii A., Fujino Y., Tsujioka Y., Takahashi M., Tsuboi Y., Wada I., Yamada T., Different expression of calreticulin and immunoglobulin binding protein in Alzheimer's disease brain Acta Neuropathologica 2000 100 2 153 160 (Pubitemid 30456137)
139. Smith I. F., Hitt B., Green K. N., Oddo S., LaFerla F. M., Enhanced caffeine-induced Ca 2+ release in the 3xTg-AD mouse model of Alzheimer's disease Journal of Neurochemistry 2005 94 6 1711 1718 (Pubitemid 41324651)
140. Chakroborty S., Goussakov I., Miller M. B., Stutzmann G. E., Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice Journal of Neuroscience 2009 29 30 9458 9470
141. Stutzmann G. E., LaFerla F. M., Parker I., Ca 2+ signaling in mouse cortical neurons studied by two-photon imaging and photoreleased inositol triphosphate Journal of Neuroscience 2003 23 3 758 765 (Pubitemid 36206166)
142. Stutzmann G. E., Caccamo A., LaFerla F. M., Parker I., Dysregulated IP 3 signaling in cortical neurons of knock-in mice expressing an Alzheimer's-linked mutation in presenilin1 results in exaggerated Ca 2+ signals and altered membrane excitability Journal of Neuroscience 2004 24 2 508 513 (Pubitemid 38112383)
143. Zhang C., Wu B., Beglopoulos V., Wines-Samuelson M., Zhang D., Dragatsis I., Sdhof T. C., Shen J., Presenilins are essential for regulating neurotransmitter release Nature 2009 460 7255 632 636
144. Tu H., Nelson O., Bezprozvanny A., Wang Z., Lee S. F., Hao Y. H., Serneels L., De Strooper B., Yu G., Bezprozvanny I., Presenilins form ER Ca 2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations Cell 2006 126 5 981 993 (Pubitemid 44310781)
145. Copanaki E., Schrmann T., Eckert A., Leuner K., Mller W. E., Prehn J. H. M., Kgel D., The amyloid precursor protein potentiates CHOP induction and cell death in response to ER Ca 2+ depletion Biochimica et Biophysica Acta 2007 1773 2 157 165 (Pubitemid 46123616)
146. Ferreiro E., Oliveira C. R., Pereira C. M. F., Involvement of endoplasmic reticulum Ca 2+ release through ryanodine and inositol 1,4,5-triphosphate receptors in the neurotoxic effects induced by the amyloid- peptide Journal of Neuroscience Research 2004 76 6 872 880 (Pubitemid 38720693)
147. Supnet C., Grant J., Kong H., Westaway D., Mayne M., Amyloid- -(142) increases ryanodine receptor-3 expression and function in neurons of TgCRND8 mice Journal of Biological Chemistry 2006 281 50 38440 38447 (Pubitemid 46041967)
148. Ricobaraza A., Cuadrado-Tejedor M., Garcia Osta A., Long-term phenylbutyrate administration prevents memory deficits in Tg2576 mice by decreasing Abeta Frontiers in Bioscience 2011 3 1375 1384
149. Wiley J. C., Pettan-Brewer C., Ladiges W. C., Phenylbutyric acid reduces amyloid plaques and rescues cognitive behavior in AD transgenic mice Aging Cell 2011 10 3 418 428
150. Wiley J. C., Meabon J. S., Frankowski H., Smith E. A., Schecterson L. C., Bothwell M., Ladiges W. C., Phenylbutyric acid rescues endoplasmic reticulum stress-induced suppression of APP proteolysis and prevents apoptosis in neuronal cells PLoS ONE 2010 5 2
151. Prasanthi J. R., Larson T., Schommer J., Ghribi O., Silencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27-hydroxycholesterol in rabbit hippocampus PLoS ONE 2011 6 10
152. Lee D. Y., Lee K. S., Lee H. J., Kim D. H., Noh Y. H., Yu K., Jung H. Y., Lee S. H., Lee J. Y., Youn Y. C., Jeong Y., Kim D. K., Lee W. B., Kim S. S., Activation of PERK signaling attenuates Abeta-mediated ER stress PloS ONE 2010 5 5
153. Casas-Tinto S., Zhang Y., Sanchez-Garcia J., Gomez-Velazquez M., Rincon-Limas D. E., Fernandez-Funez P., The ER stress factor XBP1s prevents amyloid- neurotoxicity Human Molecular Genetics 2011 20 11 2144 2160
154. Pinton P., Ferrari D., Magalhaes P., Schulze-Osthoff K., Di Virgilio F., Pozzan T., Rizzuto R., Reduced loading of intracellular Ca 2+ stores and downregulation of capacitative Ca 2+ influx in Bcl-2-overexpressing cells Journal of Cell Biology 2000 148 5 857 862
155. Bernardi P., Petronilli V., Di Lisa F., Forte M., A mitochondrial perspective on cell death Trends in Biochemical Sciences 2001 26 2 112 117 (Pubitemid 32144746)
156. Pizzo P., Pozzan T., Mitochondria-endoplasmic reticulum choreography: structure and signaling dynamics Trends in Cell Biology 2007 17 10 511 517 (Pubitemid 47562768)
157. De Brito O. M., Scorrano L., An intimate liaison: spatial organization of the endoplasmic reticulum-mitochondria relationship EMBO Journal 2010 29 16 2715 2723
158. Rizzuto R., Pinton P., Carrington W., Fay F. S., Fogarty K. E., Lifshitz L. M., Tuft R. A., Pozzan T., Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca 2+ responses Science 1998 280 5370 1763 1766 (Pubitemid 28283502)
159. Giorgi C., De Stefani D., Bononi A., Rizzuto R., Pinton P., Structural and functional link between the mitochondrial network and the endoplasmic reticulum International Journal of Biochemistry and Cell Biology 2009 41 10 1817 1827
160. Patergnani S., Suski J. M., Agnoletto C., Bononi A., Bonora M., De M. E., Giorgi C., Marchi S., Missiroli S., Poletti F., Rimessi A., Duszynski J., Wieckowski M. R., Pinton P., Calcium signaling around mitochondria associated membranes (MAMs) Cell Communication and Signaling 2011 9, article 19
161. Szabadkai G., Bianchi K., Vrnai P., De Stefani D., Wieckowski M. R., Cavagna D., Nagy A. I., Balla T., Rizzuto R., Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca 2+ channels Journal of Cell Biology 2006 175 6 901 911 (Pubitemid 44969196)
162. Simmen T., Aslan J. E., Blagoveshchenskaya A. D., Thomas L., Wan L., Xiang Y., Feliciangeli S. F., Hung C. H., Crump C. M., Thomas G., PACS-2 controls endoplasmic reticulum-mitochondria communication and Bid-mediated apoptosis EMBO Journal 2005 24 4 717 729 (Pubitemid 40396102)
163. Hayashi T., Su T. P., Sigma-1 receptor chaperones at the ER- mitochondrion interface regulate Ca 2+ signaling and cell survival Cell 2007 131 3 596 610 (Pubitemid 350017760)
164. Celsi F., Pizzo P., Brini M., Leo S., Fotino C., Pinton P., Rizzuto R., Mitochondria, calcium and cell death: a deadly triad in neurodegeneration Biochimica et Biophysica Acta 2009 1787 5 335 344
165. Csords G., Hajnczky G., SR/ER-mitochondrial local communication: calcium and ROS Biochimica et Biophysica Acta 2009 1787 11 1352 1362
166. Bravo R., Vicencio J. M., Parra V., Troncoso R., Munoz J. P., Bui M., Quiroga C., Rodriguez A. E., Verdejo H. E., Ferreira J., Iglewski M., Chiong M., Simmen T., Zorzano A., Hill J. A., Rothermel B. A., Szabadkai G., Lavandero S., Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress Journal of Cell Science 2011 124 13 2143 2152
167. Wang X., Eno C. O., Altman B. J., Zhu Y., Zhao G., Olberding K. E., Rathmell J. C., Li C., ER stress modulates cellular metabolism Biochemical Journal 2011 435 1 285 296
168. Ferreiro E., Oliveira C. R., Pereira C. M. F., The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway Neurobiology of Disease 2008 30 3 331 342
169. Ferri K. F., Kroemer G., Organelle-specific initiation of cell death pathways Nature Cell Biology 2001 3 11 E255 E263
170. Deniaud A., Sharaf El Dein O., Maillier E., Poncet D., Kroemer G., Lemaire C., Brenner C., Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis Oncogene 2008 27 3 285 299
171. Pinton P., Ferrari D., Rapizzi E., Di Virgilio F., Pozzan T., Rizzuto R., The Ca 2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action EMBO Journal 2001 20 11 2690 2701 (Pubitemid 32938554)
172. Foyouzi-Youssefi R., Arnaudeau S., Borner C., Kelley W. L., Tschopp J., Lew D. P., Demaurex N., Krause K. H., Bcl-2 decreases the free Ca 2+ concentration within the endoplasmic reticulum Proceedings of the National Academy of Sciences of the United States of America 2000 97 11 5723 5728 (Pubitemid 30367465)
173. Scorrano L., Oakes S. A., Opferman J. T., Cheng E. H., Sorcinelli M. D., Pozzan T., Korsmeyer S. J., BAX and BAK regulation of endoplasmic reticulum Ca 2+: a control point for apoptosis Science 2003 300 5616 135 139 (Pubitemid 36423046)
174. Nutt L. K., Chandra J., Pataer A., Fang B., Roth J. A., Swisher S. G., O'Neil R. G., McConkey D. J., Bax-mediated Ca 2+ mobilization promotes cytochrome c release during apoptosis Journal of Biological Chemistry 2002 277 23 20301 20308 (Pubitemid 34967324)
175. Nutt L. K., Pataer A., Pahler J., Fang B., Roth J., McConkey D. J., Swisher S. G., Bax and Bak promote apoptosis by modulating endoplasmic reticular and mitochondrial Ca 2+ stores Journal of Biological Chemistry 2002 277 11 9219 9225 (Pubitemid 34953002)
176. Klee M., Pallauf K., Alcal S., Fleischer A., Pimentel-Muos F. X., Mitochondrial apoptosis induced by BH3-only molecules in the exclusive presence of endoplasmic reticular Bak EMBO Journal 2009 28 12 1757 1768
177. Szalai G., Krishnamurthy R., Hajnczky G., Apoptosis driven by IP 3 -linked mitochondrial calcium signals EMBO Journal 1999 18 22 6349 6361 (Pubitemid 29533239)
178. Szado T., Vanderheyden V., Parys J. B., De Smedt H., Rietdorf K., Kotelevets L., Chastre E., Khan F., Landegren U., Sderberg O., Bootman M. D., Roderick H. L., Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca 2+ release and apoptosis Proceedings of the National Academy of Sciences of the United States of America 2008 105 7 2427 2432 (Pubitemid 351520530)
179. Boehning D., Patterson R. L., Sedaghat L., Glebova N. O., Kurosaki T., Snyder S. H., Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis Nature Cell Biology 2003 5 12 1051 1061 (Pubitemid 37509111)
180. Boehning D., Patterson R. L., Snyder S. H., Apoptosis and calcium: new roles for cytochrome c and inositol 1,4,5-trisphosphate Cell Cycle 2004 3 3 252 254 (Pubitemid 41359065)
181. Wang S., El-Deiry W. S., Cytochrome c: a crosslink between the mitochondria and the endoplasmic reticulum in calcium-dependent apoptosis Cancer Biology and Therapy 2004 3 1 44 46 (Pubitemid 41342416)
182. Breckenridge D. G., Stojanovic M., Marcellus R. C., Shore G. C., Caspase cleavage product of BAP31 induces mitochondrial fission through endoplasmic reticulum calcium signals, enhancing cytochrome c release to the cytosol Journal of Cell Biology 2003 160 7 1115 1127 (Pubitemid 36443879)
183. Germain M., Mathai J. P., McBride H. M., Shore G. C., Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis EMBO Journal 2005 24 8 1546 1556 (Pubitemid 40646445)
184. Szabadkai G., Simoni A. M., Chami M., Wieckowski M. R., Youle R. J., Rizzuto R., Drp-1-dependent division of the mitochondrial network blocks intraorganellar Ca 2+ waves and protects against Ca 2+ -mediated apoptosis Molecular Cell 2004 16 1 59 68 (Pubitemid 39330152)
185. Area-Gomez E., De Groof A. J. C., Boldogh I., Bird T. D., Gibson G. E., Koehler C. M., Yu W. H., Duff K. E., Yaffe M. P., Pon L. A., Schon E. A., Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria American Journal of Pathology 2009 175 5 1810 1816
186. Zampese E., Fasolato C., Kipanyula M. J., Bortolozzi M., Pozzan T., Pizzo P., Presenilin 2 modulates endoplasmic reticulum (ER)-mitochondria interactions and Ca 2+ cross-talk Proceedings of the National Academy of Sciences of the United States of America 2011 108 7 2777 2782
187. Perreault S., Bousquet O., Lauzon M., Paiement J., Leclerc N., Increased association between rough endoplasmic reticulum membranes and mitochondria in transgenic mice that express P301L tau Journal of Neuropathology and Experimental Neurology 2009 68 5 503 514
188. Costa R. O., Ferreiro E., Cardoso S. M., Oliveira C. R., Pereira C. M. F., ER stress-mediated apoptotic pathway induced by a peptide requires the presence of functional mitochondria Journal of Alzheimer's Disease 2010 20 2 625 636
189. Pickrell A. M., Fukui H., Moraes C. T., The role of cytochrome c oxidase deficiency in ROS and amyloid plaque formation Journal of Bioenergetics and Biomembranes 2009 41 5 453 456
190. Costa R. O., Ferreiro E., Martins I., Santana I., Cardoso S. M., Oliveira C. R., Pereira C. M. F., Amyloid -induced ER stress is enhanced under mitochondrial dysfunction conditions Neurobiology of Aging 2012 33 4 824.e5 824.e16
191. Princiotta M. F., Finzi D., Qian S. B., Gibbs J., Schuchmann S., Buttgereit F., Bennink J. R., Yewdell J. W., Quantitating protein synthesis, degradation, and endogenous antigen processing Immunity 2003 18 3 343 354 (Pubitemid 36351514)
192. Tu B. P., Weissman J. S., Oxidative protein folding in eukaryotes: mechanisms and consequences Journal of Cell Biology 2004 164 3 341 346 (Pubitemid 38174761)
193. Tu B. P., Ho-Schleyer S. C., Travers K. J., Weissman J. S., Biochemical basis of oxidative protein folding in the endoplasmic reticulum Science 2000 290 5496 1571 1574
194. Horibe T., Gomi M., Iguchi D., Ito H., Kitamura Y., Masuoka T., Tsujimoto I., Kimura T., Kikuchi M., Different contributions of the three CXXC motifs of human protein-disulfide isomerase-related protein to isomerase activity and oxidative refolding Journal of Biological Chemistry 2004 279 6 4604 4611 (Pubitemid 38199052)
195. Walker K. W., Gilbert H. F., Oxidation of kinetically trapped thiols by protein disulfide isomerase Biochemistry 1995 34 41 13642 13650
196. Bardwell J. C. A., McGovern K., Beckwith J., Identification of a protein required for disulfide bond formation in vivo Cell 1991 67 3 581 589 (Pubitemid 121001472)
197. Kim H. T., Russell R. L., Raina A. K., Harris P. L. R., Siedlak S. L., Zhu X., Petersen R. B., Shimohama S., Smith M. A., Perry G., Protein disulfide isomerase in Alzheimer disease Antioxidants and Redox Signaling 2000 2 3 485 489
198. Uehara T., Nakamura T., Yao D., Shi Z. Q., Gu Z., Ma Y., Masliah E., Nomura Y., Lipton S. A., S-Nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration Nature 2006 441 7092 513 517 (Pubitemid 44050153)
199. Anelli T., Alessio M., Mezghrani A., Simmen T., Talamo F., Bachi A., Sitia R., ERp44, a novel endoplasmic reticulum folding assistant of the thioredoxin family EMBO Journal 2002 21 4 835 844 (Pubitemid 34174063)
200. Otsu M., Bertoli G., Fagioli C., Guerini-Rocco E., Nerini-Molteni S., Ruffato E., Sitia R., Dynamic retention of Ero1 and Ero1 in the endoplasmic reticulum by interactions with PDI and ERp44 Antioxidants and Redox Signaling 2006 8 3-4 274 282 (Pubitemid 43741298)
201. Higo T., Hattori M., Nakamura T., Natsume T., Michikawa T., Mikoshiba K., Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44 Cell 2005 120 1 85 98 (Pubitemid 40094605)
202. Marciniak S. J., Yun C. Y., Oyadomari S., Novoa I., Zhang Y., Jungreis R., Nagata K., Harding H. P., Ron D., CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum Genes and Development 2004 18 24 3066 3077 (Pubitemid 39658175)
203. Kang S., Kang J., Kwon H., Frueh D., Seung H. Y., Wagner G., Park S., Effects of redox potential and Ca 2+ on the inositol 1,4,5-trisphosphate receptor L3-1 loop region: implications for receptor regulation Journal of Biological Chemistry 2008 283 37 25567 25575
204. Gilady S. Y., Bui M., Lynes E. M., Benson M. D., Watts R., Vance J. E., Simmen T., Ero1 requires oxidizing and normoxic conditions to localize to the mitochondria-associated membrane (MAM) Cell Stress and Chaperones 2010 15 5 619 629
205. Hajnczky G., Csords G., Madesh M., Pacher P., The machinery of local Ca 2+ signalling between sarco-endoplasmic reticulum and mitochondria Journal of Physiology 2000 529 1 69 81
206. Szabadkai G., Duchen M. R., Mitochondria: the hub of cellular Ca 2+ signaling Physiology 2008 23 2 84 94
207. Jacobson J., Duchen M. R., Mitochondrial oxidative stress and cell death in astrocytesrequirement for stored Ca 2+ and sustained opening of the permeability transition pore Journal of Cell Science 2002 115 6 1175 1188 (Pubitemid 34272482)
208. Tardif K. D., Waris G., Siddiqui A., Hepatitis C virus, ER stress, and oxidative stress Trends in Microbiology 2005 13 4 159 163 (Pubitemid 40463317)
209. Malhotra J. D., Kaufman R. J., Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxidants and Redox Signaling 2007 9 12 2277 2293 (Pubitemid 350059010)
210. Cuozzo J. W., Kaiser C. A., Competition between glutathione and protein thiols for disulphide-bond formation Nature Cell Biology 1999 1 3 130 135 (Pubitemid 129656016)
211. Chakravarthi S., Jessop C. E., Bulleid N. J., The role of glutathione in disulphide bond formation and endoplasmic-reticulum-generated oxidative stress EMBO Reports 2006 7 3 271 275
212. Hwang C., Sinskey A. J., Lodish H. F., Oxidized redox state of glutathione in the endoplasmic reticulum Science 1992 257 5076 1496 1502
213. Adams J. D., Klaidman L. K., Odunze I. N., Shen H. C., Miller C. A., Alzheimer's and Parkinson's disease: brain levels of glutathione, glutathione disulfide, and vitamin E Molecular and Chemical Neuropathology 1991 14 3 213 226
214. Aksenov M. Y., Markesbery W. R., Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease Neuroscience Letters 2001 302 2-3 141 145 (Pubitemid 32274229)
215. Liu H., Wang H., Shenvi S., Hagen T. M., Liu R. M., Glutathione metabolism during aging and in Alzheimer disease Annals of the New York Academy of Sciences 2004 1019 346 349 (Pubitemid 38951332)
216. Apelt J., Bigl M., Wunderlich P., Schliebs R., Aging-related increase in oxidative stress correlates with developmental pattern of beta-secretase activity and beta-amyloid plaque formation in transgenic Tg2576 mice with Alzheimer-like pathology International Journal of Developmental Neuroscience 2004 22 7 475 484 (Pubitemid 39311436)
217. White A. R., Bush A. I., Beyreuther K., Masters C. L., Cappai R., Exacerbation of copper toxicity in primary neuronal cultures depleted of cellular glutathione Journal of Neurochemistry 1999 72 5 2092 2098 (Pubitemid 29186015)
218. Cullinan S. B., Zhang D., Hannink M., Arvisais E., Kaufman R. J., Diehl J. A., Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival Molecular and Cellular Biology 2003 23 20 7198 7209 (Pubitemid 37211002)
219. Nguyen T., Nioi P., Pickett C. B., The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress Journal of Biological Chemistry 2009 284 20 13291 13295
220. Cullinan S. B., Diehl J. A., PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress Journal of Biological Chemistry 2004 279 19 20108 20117 (Pubitemid 38623455)
221. Ramsey C. P., Glass C. A., Montgomery M. B., Lindl K. A., Ritson G. P., Chia L. A., Hamilton R. L., Chu C. T., Jordan-Sciutto K. L., Expression of Nrf2 in neurodegenerative diseases Journal of Neuropathology and Experimental Neurology 2007 66 1 75 85 (Pubitemid 46066791)
222. Kanninen K., Malm T. M., Jyrkknen H. K., Goldsteins G., Keksa-Goldsteine V., Tanila H., Yamamoto M., Yl-Herttuala S., Levonen A. L., Koistinaho J., Nuclear factor erythroid 2-related factor 2 protects against beta amyloid Molecular and Cellular Neuroscience 2008 39 3 302 313
223. Li G., Mongillo M., Chin K. T., Harding H., Ron D., Marks A. R., Tabas I., Role of ERO1- -mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis Journal of Cell Biology 2009 186 6 783 792
224. Timmins J. M., Ozcan L., Seimon T. A., Li G., Malagelada C., Backs J., Backs T., Bassel-Duby R., Olson E. N., Anderson M. E., Tabas I., Calcium/calmodulin-dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways Journal of Clinical Investigation 2009 119 10 2925 2941
225. Li G., Scull C., Ozcan L., Tabas I., NADPH oxidase links endoplasmic reticulum stress, oxidative stress, and PKR activation to induce apoptosis Journal of Cell Biology 2010 191 6 1113 1125
226. De La Monte S. M., Wands J. R., Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease Journal of Alzheimer's Disease 2006 9 2 167 181 (Pubitemid 44088244)
227. Berridge M. V., Tan A. S., High-capacity redox control at the plasma membrane of mammalian cells: trans-membrane, cell surface, and serum NADH-oxidases Antioxidants and Redox Signaling 2000 2 2 231 242 (Pubitemid 30445935)
228. Ermak G., Davies K. J. A., Calcium and oxidative stress: from cell signaling to cell death Molecular Immunology 2002 38 10 713 721 (Pubitemid 34158874)
229. Squier T. C., Bigelow D. J., Protein oxidation and age-dependent alterations in calcium homeostasis Frontiers in Bioscience 2000 5 D504 D526
230. Viner R. I., Williams T. D., Schneich C., Nitric oxide-dependent modification of the sarcoplasmic reticulum Ca- ATPase: localization of cysteine target sites Free Radical Biology and Medicine 2000 29 6 489 496
231. Blennow K., Hampel H., Weiner M., Zetterberg H., Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nature Reviews Neurology 2010 6 3 131 144
232. Dubois B., Feldman H. H., Jacova C., DeKosky S. T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P. J., Scheltens P., Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria The Lancet Neurology 2007 6 8 734 746 (Pubitemid 47058377)
233. McKhann G. M., Knopman D. S., Chertkow H., Hyman B. T., Jack C. R., Kawas C. H., Klunk W. E., Koroshetz W. J., Manly J. J., Mayeux R., Mohs R. C., Morris J. C., Rossor M. N., Scheltens P., Carrillo M. C., Thies B., Weintraub S., Phelps C. H., The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimer's and Dementia 2011 7 3 263 269
234. Bourdel-Marchasson I., Delmas-Beauviex M. C., Peuchant E., Richard-Harston S., Decamps A., Reigneir B., Emeriau J. P., Rainfray M., Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients Age and Ageing 2001 30 3 235 241 (Pubitemid 32684904)
235. Polidori M. C., Mecocci P., Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease Journal of Alzheimer's Disease 2002 4 6 517 522 (Pubitemid 36142841)
236. Aybek H., Ercan F., Aslan D., ahiner T., Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey Clinical Biochemistry 2007 40 3-4 172 176 (Pubitemid 46108698)
237. Casado A., Encarnacion Lopez-Fernandez M., Concepcin Casado M., De La Torre R., Lipid peroxidation and antioxidant enzyme activities in vascular and alzheimer dementias Neurochemical Research 2008 33 3 450 458 (Pubitemid 351230446)
238. Padurariu M., Ciobica A., Hritcu L., Stoica B., Bild W., Stefanescu C., Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease Neuroscience Letters 2010 469 1 6 10
239. Torres L. L., Quaglio N. B., de Souza G. T., Garcia R. T., Dati L. M., Moreira W. L., Loureiro A. P., de Souza-Talarico J. N., Smid J., Porto C. S., Bottino C. M., Nitrini R., Barros S. B., Camarini R., Marcourakis T., Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease Journal of Alzheimer's Disease 2011 26 1 59 68
240. Kawamoto E. M., Munhoz C. D., Glezer I., Bahia V. S., Caramelli P., Nitrini R., Gorjo R., Curi R., Scavone C., Marcourakis T., Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease Neurobiology of Aging 2005 26 6 857 864 (Pubitemid 40249488)
241. Baldeiras I., Santana I., Proena M. T., Garrucho M. H., Pascoal R., Rodrigues A., Duro D., Oliveira C. R., Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease Journal of Alzheimer's Disease 2008 15 1 117 128
242. Ceballos-Picot I., Merad-Boudia M., Nicole A., Thevenin M., Hellier G., Legrain S., Berr C., Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's typeplace of the extracellular glutathione peroxidase Free Radical Biology and Medicine 1996 20 4 579 587 (Pubitemid 26097275)
243. McGrath L. T., McGleenon B. M., Brennan S., McColl D., McIlroy S., Passmore A. P., Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde QJM: Monthly Journal of the Association of Physicians 2001 94 9 485 490 (Pubitemid 32894467)
244. Galbusera C., Facheris M., Magni F., Galimberti G., Sala G., Tremolada L., Isella V., Guerini F. R., Appollonio I., Galli-Kienle M., Ferrarese C., Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients Current Alzheimer Research 2004 1 2 103 109
245. Lovell M. A., Ehmann W. D., Mattson M. P., Markesbery W. R., Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease Neurobiology of Aging 1997 18 5 457 461 (Pubitemid 27497140)
246. Calabrese V., Sultana R., Scapagnini G., Guagliano E., Sapienza M., Bella R., Kanski J., Pennisi G., Mancuso C., Stella A. M. G., Butterfield D. A., Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease Antioxidants and Redox Signaling 2006 8 11-12 1975 1986 (Pubitemid 46489625)
247. Sinclair A. J., Bayer A. J., Johnston J., Warner C., Maxwell S. R., Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia International Journal of Geriatric Psychiatry 1998 13 12 840 845 (Pubitemid 28564482)
248. Cecchi C., Fiorillo C., Sorbi S., Latorraca S., Nacmias B., Bagnoli S., Nassi P., Liguri G., Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients Free Radical Biology and Medicine 2002 33 10 1372 1379 (Pubitemid 35284921)
249. Montine T. J., Markesbery W. R., Morrow J. D., Roberts L. J., Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease Annals of Neurology 1998 44 3 410 413 (Pubitemid 28421451)
250. Montine T. J., Beal M. F., Cudkowicz M. E., O'Donnell H., Margolin R. A., McFarland L., Bachrach A. F., Zackert W. E., Roberts L. J., Morrow J. D., Increased CSF F2-isoprostane concentration in probable AD Neurology 1999 52 3 562 565 (Pubitemid 29075604)
251. Pratic D., Clark C. M., Liun F., Lee V. Y. M., Trojanowski J. Q., Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease Archives of Neurology 2002 59 6 972 976 (Pubitemid 34640757)
252. Pratico D., Clark C. M., Lee V. M., Trojanowski J. Q., Rokach J., FitzGerald G. A., Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity Annals of Neurology 2000 48 5 809 812
253. Montine T. J., Kaye J. A., Montine K. S., McFarland L., Morrow J. D., Quinn J. F., Cerebrospinal fluid A 42, tau, and F2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls Archives of Pathology and Laboratory Medicine 2001 125 4 510 512 (Pubitemid 32291556)
254. De Leon M. J., Desanti S., Zinkowski R., Mehta P. D., Pratico D., Segal S., Clark C., Kerkman D., Debernardis J., Li J., Lair L., Reisberg B., Tsui W., Rusinek H., MRI and CSF studies in the early diagnosis of Alzheimer's disease Journal of Internal Medicine 2004 256 3 205 223 (Pubitemid 39222990)
255. de Leon M. J., Mosconi L., Li J., De Santi S., Yao Y., Tsui W. H., Pirraglia E., Rich K., Javier E., Brys M., Glodzik L., Switalski R., Saint Louis L. A., Pratico D., Longitudinal CSF isoprostane and MRI atrophy in the progression to AD Journal of Neurology 2007 254 12 1666 1675
256. Brys M., Pirraglia E., Rich K., Rolstad S., Mosconi L., Switalski R., Glodzik-Sobanska L., De Santi S., Zinkowski R., Mehta P., Pratico D., Saint Louis L. A., Wallin A., Blennow K., de Leon M. J., Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment Neurobiology of Aging 2009 30 5 682 690
257. De Leon M. J., DeSanti S., Zinkowski R., Mehta P. D., Pratico D., Segal S., Rusinek H., Li J., Tsui W., Saint Louis L. A., Clark C. M., Tarshish C., Li Y., Lair L., Javier E., Rich K., Lesbre P., Mosconi L., Reisberg B., Sadowski M., DeBernadis J. F., Kerkman D. J., Hampel H., Wahlund L. O., Davies P., Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment Neurobiology of Aging 2006 27 3 394 401 (Pubitemid 43185324)
258. Quinn J. F., Montine K. S., Moore M., Morrow J. D., Kaye J. A., Montine T. J., Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease Journal of Alzheimer's Disease 2004 6 1 93 97 (Pubitemid 38418561)
259. Kim K. M., Jung B. H., Paeng K. J., Kim I., Chung B. C., Increased urinary F2-isoprostanes levels in the patients with Alzheimer's disease Brain Research Bulletin 2004 64 1 47 51 (Pubitemid 38953468)
260. Montine T. J., Quinn J. F., Milatovic D., Silbert L. C., Dang T., Sanchez S., Terry E., Roberts L. J., Kaye J. A., Morrow J. D., Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease Annals of Neurology 2002 52 2 175 179 (Pubitemid 34810597)
261. Irizarry M. C., Yao Y., Hyman B. T., Growdon J. H., Pratic D., Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease Neurodegenerative Diseases 2007 4 6 403 405 (Pubitemid 47557280)
262. Zafrilla P., Mulero J., Xandri J. M., Santo E., Caravaca G., Morillas J. M., Oxidative stress in Alzheimer patients in different stages of the disease Current Medicinal Chemistry 2006 13 9 1075 1083
263. Bermejo P., Martn-Aragn S., Bened J., Susn C., Felici E., Gil P., Ribera J. M., Villar. M., Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment Free Radical Research 2008 42 2 162 170 (Pubitemid 351298365)
264. Hensley K., Maidt M. L., Yu Z., Sang H., Markesbery W. R., Floyd R. A., Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation Journal of Neuroscience 1998 18 20 8126 8132 (Pubitemid 28464991)
265. Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., Isobe C., Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease Neuroscience Letters 1999 269 1 52 54 (Pubitemid 29305700)
266. Ryberg H., Sderling A. S., Davidsson P., Blennow K., Caidahl K., Persson L. I., Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease Neurochemistry International 2004 45 1 57 62 (Pubitemid 38479564)
267. Lovell M. A., Gabbita S. P., Markesbery W. R., Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF Journal of Neurochemistry 1999 72 2 771 776 (Pubitemid 29055242)
268. Lovell M. A., Markesbery W. R., Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid Archives of Neurology 2001 58 3 392 396 (Pubitemid 32217455)
269. Isobe C., Abe T., Terayama Y., Levels of reduced and oxidized coenzyme Q-10 and 8-hydroxy-2′- deoxyguanosine in the CSF of patients with Alzheimer's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process Journal of Neurology 2010 257 3 399 404
270. Mecocci P., Polidori M. C., Ingegni T., Cherubini A., Chionne F., Cecchetti R., Senin U., Oxidative damage to DNA in lymphocytes from AD patients Neurology 1998 51 4 1014 1017 (Pubitemid 28473393)
271. Migliore L., Fontana I., Trippi F., Colognato R., Copped F., Tognoni G., Nucciarone B., Siciliano G., Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients Neurobiology of Aging 2005 26 5 567 573 (Pubitemid 40228745)
272. Hee Lee S., Kim I., Chul Chung B., Increased urinary level of oxidized nucleosides in patients with mild-to-moderate Alzheimer's disease Clinical Biochemistry 2007 40 13-14 936 938 (Pubitemid 47307331)
273. Abe T., Tohgi H., Isobe C., Murata T., Sato C., Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease Journal of Neuroscience Research 2002 70 3 447 450 (Pubitemid 35222381)
274. Fernandes M. A. S., Santana I., Januario C., Cunha L., Oliveira C. R., Decreased superoxide dismutase activity in erythrocytes from patients with Alzheimer's disease Medical Science Research 1993 21 18 679 682 (Pubitemid 23284397)
275. Rinaldi P., Polidori M. C., Metastasio A., Mariani E., Mattioli P., Cherubini A., Catani M., Cecchetti R., Senin U., Mecocci P., Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease Neurobiology of Aging 2003 24 7 915 919 (Pubitemid 36962976)
276. Mecocci P., Cristina Polidori M., Cherubini A., Ingegni T., Mattioli P., Catani M., Rinaldi P., Cecchetti R., Stahl W., Senin U., Flint Beal M., Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease Archives of Neurology 2002 59 5 794 798 (Pubitemid 34517762)
277. Baldeiras I., Santana I., Proena M. T., Garrucho M. H., Pascoal R., Rodrigues A., Duro D., Oliveira C. R., Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairment Journal of Alzheimer's Disease 2010 21 4 1165 1177
278. Azzi A., Stocker A., Vitamin E: non-antioxidant roles Progress in Lipid Research 2000 39 3 231 255 (Pubitemid 30224705)
279. Jiménez-Jiménez F. J., De Bustos F., Molina J. A., Benito-Len J., Talln-Barranco A., Gasalla T., Ort-Pareja M., Guillamn F., Rubio J. C., Arenas J., Enrquez-de-Salamanca R., Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease Journal of Neural Transmission 1997 104 6-7 703 710 (Pubitemid 27474683)
280. Williamson K. S., Prasad Gabbita S., Mou S., West M., Pye Q. N., Markesbery W. R., Cooney R. V., Grammas P., Reimann-Philipp U., Floyd R. A., Hensley K., The nitration product 5-nitro- -tocopherol is increased in the Alzheimer brain Nitric Oxide 2002 6 2 221 227 (Pubitemid 34848445)
281. Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A., Cole G. M., The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse Journal of Neuroscience 2001 21 21 8370 8377 (Pubitemid 33051435)
282. Conte V., Uryu K., Fujimoto S., Yao Y., Rokach J., Longhi L., Trojanowski J. Q., Lee V. M. Y., McIntosh T. K., Pratic D., Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury Journal of Neurochemistry 2004 90 3 758 764 (Pubitemid 38989408)
283. Sano M., Ernesto C., Thomas R. G., Klauber M. R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C. W., Pfeiffer E., Schneider L. S., Thal L. J., A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease New England Journal of Medicine 1997 336 17 1216 1222 (Pubitemid 27183651)
284. Le Bars P. L., Velasco F. M., Ferguson J. M., Dessain E. C., Kieser M., Hoerr R., Influence of the severity of cognitive impairment on the effect of the Ginkgo biloba extract EGb 761 in Alzheimer's disease Neuropsychobiology 2002 45 1 19 26 (Pubitemid 34117724)
285. Petersen R. C., Thomas R. G., Grundman M., Bennett D., Doody R., Ferris S., Galasko D., Jin S., Kaye J., Levey A., Pfeiffer E., Sano M., Van Dyck C. H., Thal L. J., Vitamin E and donepezil for the treatment of mild cognitive impairment New England Journal of Medicine 2005 352 23 2379 2388 (Pubitemid 40958434)
286. Jack C. R. Jr., Petersen R. C., Grundman M., Jin S., Gamst A., Ward C. P., Sencakova D., Doody R. S., Thal L. J., Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI Neurobiology of Aging 2008 29 9 1285 1295 (Pubitemid 351970601)
287. Pratic D., Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows Annals of the New York Academy of Sciences 2008 1147 70 78
288. Kamat C. D., Gadal S., Mhatre M., Williamson K. S., Pye Q. N., Hensley K., Antioxidants in central nervous system diseases: preclinical promise and translational challenges Journal of Alzheimer's Disease 2008 15 3 473 493
289. Brewer G. J., Why vitamin e therapy fails for treatment of Alzheimer's disease Journal of Alzheimer's Disease 2010 19 1 27 30
290. Moreira P. I., Zhu X., Wang X., Lee H. G., Nunomura A., Petersen R. B., Perry G., Smith M. A., Mitochondria: a therapeutic target in neurodegeneration Biochimica et Biophysica Acta 2010 1802 1 212 220
291. Dumont M., Lin M. T., Beal M. F., Mitochondria and antioxidant targeted therapeutic strategies for Alzheimer's disease Journal of Alzheimer's Disease 2010 20 supplement 2 S633 S643
292. Perry G., Nunomura A., Hirai K., Zhu X., Prez M., Avila J., Castellani R. J., Atwood C. S., Aliev G., Sayre L. M., Takeda A., Smith M. A., Is oxidative damage the fundamental pathogenic mechanism of Alzheimer's and other neurodegenerative diseases? Free Radical Biology and Medicine 2002 33 11 1475 1479 (Pubitemid 35351590)